Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix gross margin
Gross margin is gross profit as a percentage of revenue.
Soligenix's gross margin for the twelve months ending Dec 31, 2024 was 0.0%. For fiscal 2024 it was 0.0%, against 11.6% the year before. The highest annual figure on record is 72.5% in fiscal 2011.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0.0% | −11.6 |
| FY2023 | Dec 31, 2023 | 11.6% | −30.4 |
| FY2022 | Dec 31, 2022 | 42.0% | +30.4 |
| FY2021 | Dec 31, 2021 | 11.6% | −11.2 |
| FY2020 | Dec 31, 2020 | 22.8% | −0.1 |
| FY2019 | Dec 31, 2019 | 22.9% | +10.7 |
| FY2018 | Dec 31, 2018 | 12.3% | −8.4 |
| FY2017 | Dec 31, 2017 | 20.7% | +1.4 |
| FY2016 | Dec 31, 2016 | 19.3% | −2.2 |
| FY2015 | Dec 31, 2015 | 21.5% | −3.0 |
| FY2014 | Dec 31, 2014 | 24.6% | +3.5 |
| FY2013 | Dec 31, 2013 | 21.1% | +3.5 |
| FY2012 | Dec 31, 2012 | 17.5% | −54.9 |
| FY2011 | Dec 31, 2011 | 72.5% | +56.6 |
| FY2010 | Dec 31, 2010 | 15.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | 0.0% | −11.1 |
| Q1 FY2024 | Mar 31, 2024 | 0.0% | −12.1 |
| Q4 FY2023 | Dec 31, 2023 | 9.5% | −53.4 |
| Q3 FY2023 | Sep 30, 2023 | 15.3% | −6.8 |
| Q2 FY2023 | Jun 30, 2023 | 11.1% | −4.4 |
| Q1 FY2023 | Mar 31, 2023 | 12.1% | −38.9 |
| Q4 FY2022 | Dec 31, 2022 | 62.9% | +48.4 |
| Q3 FY2022 | Sep 30, 2022 | 22.1% | +11.4 |
| Q2 FY2022 | Jun 30, 2022 | 15.5% | +10.6 |
| Q1 FY2022 | Mar 31, 2022 | 51.0% | +33.9 |
| Q4 FY2021 | Dec 31, 2021 | 14.5% | −10.2 |
| Q3 FY2021 | Sep 30, 2021 | 10.7% | −25.8 |
| Q2 FY2021 | Jun 30, 2021 | 4.9% | −23.2 |
| Q1 FY2021 | Mar 31, 2021 | 17.1% | +6.8 |
| Q4 FY2020 | Dec 31, 2020 | 24.7% | +5.8 |
| Q3 FY2020 | Sep 30, 2020 | 36.5% | +24.0 |
| Q2 FY2020 | Jun 30, 2020 | 28.1% | +17.7 |
| Q1 FY2020 | Mar 31, 2020 | 10.3% | −3.2 |
| Q1 FY2019 | Mar 31, 2019 | 18.9% | +6.4 |
| Q4 FY2018 | Dec 31, 2018 | 12.5% | −4.3 |
| Q3 FY2018 | Sep 30, 2018 | 10.4% | −8.7 |
| Q2 FY2018 | Jun 30, 2018 | 13.4% | −18.2 |
| Q1 FY2018 | Mar 31, 2018 | 12.6% | −5.7 |
| Q4 FY2017 | Dec 31, 2017 | 16.8% | −10.8 |
| Q3 FY2017 | Sep 30, 2017 | 19.1% | +8.0 |
| Q2 FY2017 | Jun 30, 2017 | 31.7% | +5.8 |
| Q1 FY2017 | Mar 31, 2017 | 18.3% | +3.1 |
| Q4 FY2016 | Dec 31, 2016 | 27.7% | – |
| Q3 FY2016 | Sep 30, 2016 | 11.1% | – |
| Q2 FY2016 | Jun 30, 2016 | 25.9% | – |
| Q1 FY2016 | Mar 31, 2016 | 15.2% | – |
See a number that looks wrong?